JO

James Daniel OSBORNE

CL Cancer Research Technology Limited: 10 patents #27 of 493Top 6%
AL Astex Therapeutics Limited: 7 patents #35 of 199Top 20%
AS Almirall, S.A.: 1 patents #37 of 81Top 50%
📍 Saffron Walden, GB: #30 of 225 inventorsTop 15%
Overall (All Time): #444,468 of 4,157,543Top 15%
11
Patents All Time

Issued Patents All Time

Showing 1–11 of 11 patents

Patent #TitleCo-InventorsDate
12077526 Isoindolinone inhibitors of the MDM2-P53 interaction and process for making them Steven Howard, Benjamin David CONS, Jeffrey David ST. DENIS, Rhian Sara HOLVEY, Guillaume François PARRA +11 more 2024-09-03
12071429 Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity Gianni Chessari, Steven Howard, Ildiko Maria Buck, Benjamin David CONS, Christopher Norbert Johnson +16 more 2024-08-27
11787792 5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2 Pyridyl]Amino]Pyrazine-2-carbonitrile and therapeutic uses thereof Ian Collins, Thomas Peter Matthews, Tatiana Faria Da Fonseca Mchardy, Michael Lainchbury, Michael Ian Walton +1 more 2023-10-17
11603367 Isoindolinone inhibitors of the MDM2-P53 interaction and process for making them Steven Howard, Jeffrey David ST. DENIS, Charlotte Mary Griffiths-Jones, Steven Douglas Hiscock, Alan Richard BURNS +11 more 2023-03-14
11261171 Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity Gianni Chessari, Steven Howard, Ildiko Maria Buck, Benjamin David CONS, Christopher Norbert Johnson +16 more 2022-03-01
10981898 Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity Gianni Chessari, Steven Howard, Ildiko Maria Buck, Benjamin David CONS, Christopher Norbert Johnson +16 more 2021-04-20
10544132 Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity Gianni Chessari, Steven Howard, Ildiko Maria Buck, Benjamin David CONS, Christopher Norbert Johnson +16 more 2020-01-28
10526311 Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity Gianni Chessari, Steven Howard, Ildiko Maria Buck, Benjamin David CONS, Christopher Norbert Johnson +16 more 2020-01-07
10259806 5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2 pyridyl]amino]pyrazine-2-carbonitrile and therapeutic uses thereof Ian Collins, Thomas Peter Matthews, Tatiana Faria Da Fonseca Mchardy, Michael Lainchbury, Michael Ian Walton +1 more 2019-04-16
10214509 Amino-substituted heterocyclic derivatives as sodium channel inhibitors James E. Duffy, Mark Stuart Chambers, Alastair Rae, Isabelle Anne LEMASSON, Michael Daniel Goldsmith +2 more 2019-02-26
9663503 5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2-pyridyl]amino]pyrazine-2-carbonitrile and therapeutic uses thereof Ian Collins, Thomas Peter Matthews, Tatiana Faria Da Fonseca Mchardy, Michael Lainchbury, Michael Ian Walton +1 more 2017-05-30